Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072345
Status:
COMPLETED
Last Update Posted:
2013-01-18
First Post:
2003-11-04
Brief Title:
Temozolomide Thalidomide and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Melanoma Skin |
| Intraocular Melanoma |